BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38448965)

  • 1. Corneal Regeneration Using Gene Therapy Approaches.
    Sarkar S; Panikker P; D'Souza S; Shetty R; Mohan RR; Ghosh A
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.
    Wiedemann J; Hos D; Limburg E; Zettelmeyer U; Schiller P; Franklin J; Bachmann B; Böhringer D; Dietrich-Ntoukas T; Fuchsluger TA; Geerling G; Lang SJ; Mayer WJ; Priglinger S; Reinhard T; Seitz B; Cursiefen C
    Trials; 2024 Mar; 25(1):169. PubMed ID: 38448965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival.
    Hou Y; Bock F; Hos D; Cursiefen C
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting Edge: Novel Treatment Options Targeting Corneal Neovascularization to Improve High-Risk Corneal Graft Survival.
    Cursiefen C; Hos D
    Cornea; 2021 Dec; 40(12):1512-1518. PubMed ID: 34116541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preconditioning of vascularized high-risk eyes using fine-needle diathermy and cross-linking].
    Matthaei M; Hos D; Bock F; Le VNH; Hou Y; Schaub F; Siebelmann S; Zhang W; Roters S; Bachmann BO; Cursiefen C
    Ophthalmologe; 2021 Jun; 118(6):553-560. PubMed ID: 33961088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limbal stem cell transplantation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2008; 8(7):1-58. PubMed ID: 23074512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descemet's membrane endothelial keratoplasty is the predominant keratoplasty procedure in Germany since 2016: a report of the DOG-section cornea and its keratoplasty registry.
    Flockerzi E; Turner C; Seitz B; Collaborators GSG;
    Br J Ophthalmol; 2024 May; 108(5):646-653. PubMed ID: 37586835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel role of lymphatic vessels in the pathogenesis of ocular diseases.
    Clahsen T; Hadrian K; Notara M; Schlereth SL; Howaldt A; Prokosch V; Volatier T; Hos D; Schroedl F; Kaser-Eichberger A; Heindl LM; Steven P; Bosch JJ; Steinkasserer A; Rokohl AC; Liu H; Mestanoglu M; Kashkar H; Schumacher B; Kiefer F; Schulte-Merker S; Matthaei M; Hou Y; Fassbender S; Jantsch J; Zhang W; Enders P; Bachmann B; Bock F; Cursiefen C
    Prog Retin Eye Res; 2023 Sep; 96():101157. PubMed ID: 36759312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal Crosslinking to Regress Pathologic Corneal Neovascularization Before High-Risk Keratoplasty.
    Schaub F; Hou Y; Zhang W; Bock F; Hos D; Cursiefen C
    Cornea; 2021 Feb; 40(2):147-155. PubMed ID: 33395116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot Study.
    Hos D; Le VNH; Hellmich M; Siebelmann S; Roters S; Bachmann BO; Cursiefen C
    Transplant Direct; 2019 May; 5(5):e452. PubMed ID: 31165087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival.
    Hou Y; Le VNH; Tóth G; Siebelmann S; Horstmann J; Gabriel T; Bock F; Cursiefen C
    Am J Transplant; 2018 Dec; 18(12):2873-2884. PubMed ID: 29673063
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.